MCK - McKesson Corporation
After hours:
Chart Events
Triple Moving Average Crossover
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 389.23 |
| Open | 386.13 |
| Bid | 386.00 x 800 |
| Ask | 392.00 x 1300 |
| Day's Range | 385.31 - 391.49 |
| 52 Week Range | 298.69 - 401.78 |
| Volume | |
| Avg. Volume | 1,001,779 |
| Market Cap | 52.906B |
| Beta (5Y Monthly) | 0.58 |
| PE Ratio (TTM) | 15.53 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 2.16 (0.55%) |
| Ex-Dividend Date | May 31, 2023 |
| 1y Target Est | N/A |
Fair Value
Related Research
- Business Wire
McKesson Corporation Reports Fiscal 2023 Fourth-Quarter and Full-Year Results and Raises Long-Term Segment Growth Targets
IRVING, Texas, May 08, 2023--McKesson Corporation (NYSE: MCK) has released its fiscal 2023 fourth-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
- Business Wire
McKesson Corporation Declares Quarterly Dividend
IRVING, Texas, April 27, 2023--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 54 cents per share of common stock. The dividend will be payable on July 3, 2023, to stockholders of record on June 1, 2023.
- Business Wire
McKesson Corporation Announces Fourth-quarter Fiscal 2023 Earnings Release Date
IRVING, Texas, March 27, 2023--McKesson Corporation (NYSE: MCK) will release its fourth-quarter and full-year fiscal 2023 financial results after market close on Monday, May 8, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
- Business Wire
McKesson Corporation Reports Fiscal 2023 Third-Quarter Results
IRVING, Texas, February 01, 2023--McKesson Corporation (NYSE: MCK) has released its fiscal 2023 third-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
- Business Wire
McKesson Corporation Announces Third-Quarter Fiscal 2023 Earnings Release Date
IRVING, Texas, December 28, 2022--McKesson Corporation (NYSE: MCK) will release its third-quarter fiscal 2023 financial results after market close on Wednesday, February 1, 2023. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
- Business Wire
McKesson Corporation Reports Fiscal 2023 Second-Quarter Results and Raises Full-Year Guidance
IRVING, Texas, November 01, 2022--McKesson Corporation (NYSE: MCK) has released its fiscal 2023 second-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
- Business Wire
McKesson Corporation Extends Pharmaceutical Distribution Agreement With CVS Health
IRVING, Texas, September 29, 2022--McKesson Corporation (NYSE: MCK) today announced that it has signed an agreement in principle to extend its partnership with CVS Health to distribute pharmaceuticals to mail order and specialty pharmacies, retail pharmacies and distribution centers through June 2027.
- PR Newswire
McKesson Signs Agreement to Acquire Rx Savings Solutions
McKesson Corporation (NYSE: MCK) today announced that it has signed a definitive agreement to acquire Rx Savings Solutions (RxSS), a prescription price transparency and benefit insight company that offers affordability and adherence solutions to health plans and employers, reaching more than 17 million current patients.
- Business Wire
McKesson Names LeAnn B. Smith as Next Chief Human Resources Officer
IRVING, Texas, September 13, 2022--McKesson Corporation (NYSE:MCK) today announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer (CHRO). Ms. Smith will succeed Tracy L. Faber, McKesson’s current CHRO, who will be retiring after an accomplished 11-year tenure with McKesson. These changes are expected to be effective December 1, 2022.
- Business Wire
McKesson Corporation Reports Fiscal 2023 First-Quarter Results
IRVING, Texas, August 03, 2022--McKesson Corporation (NYSE: MCK) has released its fiscal 2023 first-quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results.
- Business Wire
McKesson Raises Quarterly Dividend by 15% to $0.54 Per Share
IRVING, Texas, July 25, 2022--The Board of Directors of McKesson Corporation (NYSE:MCK) declared on July 22, 2022 a regular dividend of $0.54 per share of common stock, a 15% increase from $0.47 per share in the prior quarter. The dividend will be payable on October 3, 2022, to stockholders of record on September 1, 2022.
- Business Wire
McKesson Corporation Announces First Quarter Fiscal 2023 Earnings Release Date
IRVING, Texas, June 29, 2022--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2023 financial results after market close on Wednesday, August 3, 2022. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results.
- Business Wire
McKesson and HCA Healthcare Announce Plans to Form an Oncology Research Joint Venture to Advance Cancer Care and Increase Access to Oncology Clinical Research
IRVING, Texas & NASHVILLE, Tenn., June 23, 2022--McKesson Corporation (NYSE: MCK) and HCA Healthcare, Inc. (NYSE: HCA) announced today an agreement to form a joint venture combining McKesson’s US Oncology Research (USOR) and HCA Healthcare’s Sarah Cannon Research Institute (SCRI). USOR is the research arm of McKesson’s The US Oncology Network and draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials. SCRI, which is the research
